These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385 [TBL] [Abstract][Full Text] [Related]
26. High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study. Cristell N; Cianflone D; Durante A; Ammirati E; Vanuzzo D; Banfi M; Calori G; Latib A; Crea F; Marenzi G; De Metrio M; Moretti L; Li H; Uren NG; Hu D; Maseri A; J Am Coll Cardiol; 2011 Dec; 58(25):2654-61. PubMed ID: 22152952 [TBL] [Abstract][Full Text] [Related]
28. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention]. He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Urbano-Moral JA; Lopez-Haldon JE; Fernandez M; Mancha F; Sanchez A; Rodriguez-Puras MJ; Villa M; Lopez-Pardo F; Diaz de la Llera L; Valle JI; Martinez A Heart; 2012 Aug; 98(15):1153-9. PubMed ID: 22572051 [TBL] [Abstract][Full Text] [Related]
30. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models. Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505 [TBL] [Abstract][Full Text] [Related]
31. High-sensitivity troponin level pre-catheterization predicts adverse cardiovascular outcomes after primary angioplasty for ST-elevation myocardial infarction. Wang TK; Snow TA; Chen Y; Rostom H; White JM; Stewart JT; Webster MW; Ruygrok PN; Watson T; White HD Eur Heart J Acute Cardiovasc Care; 2014 Jun; 3(2):118-25. PubMed ID: 24576774 [TBL] [Abstract][Full Text] [Related]
32. High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention. Bjerre M; Pedersen SH; Møgelvang R; Lindberg S; Jensen JS; Galatius S; Flyvbjerg A Eur J Prev Cardiol; 2013 Dec; 20(6):922-9. PubMed ID: 23613225 [TBL] [Abstract][Full Text] [Related]
33. The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction. Foussas SG; Zairis MN; Makrygiannis SS; Manousakis SJ; Anastassiadis FA; Apostolatos CS; Patsourakos NG; Glyptis MP; Papadopoulos JK; Xenos DC; Adamopoulou EN; Olympios CD; Argyrakis SK Heart; 2007 Aug; 93(8):952-6. PubMed ID: 17344331 [TBL] [Abstract][Full Text] [Related]
34. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction. Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611 [TBL] [Abstract][Full Text] [Related]
35. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction]. Cağli KE; Topaloğlu S; Aras D; Günel EN; Ozlü MF; Uygur B; Baysal E; Sen N Turk Kardiyol Dern Ars; 2009 Jan; 37(1):19-25. PubMed ID: 19225249 [TBL] [Abstract][Full Text] [Related]
36. Cardiac troponin elevation pattern in patients undergoing a primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: characterization and relationship with cardiovascular events during hospitalization. Buber J; Laish-Farkash A; Koren-Morag N; Fefer P; Segev A; Hod H; Matetzky S Coron Artery Dis; 2015 Sep; 26(6):503-9. PubMed ID: 26061436 [TBL] [Abstract][Full Text] [Related]
37. Relationship of Serial High-Sensitivity C-Reactive Protein Changes to Long-term Clinical Outcomes in Stabilised Patients After Myocardial Infarction. Lee M; Lee K; Kim DW; Cho JS; Kim TS; Kwon J; Kim CJ; Park CS; Kim HY; Yoo KD; Jeon DS; Chang K; Kim MC; Jeong MH; Ahn Y; Park MW Can J Cardiol; 2022 Jan; 38(1):92-101. PubMed ID: 34737035 [TBL] [Abstract][Full Text] [Related]
38. Long-Term Outcomes in Survivors of Early Ventricular Arrhythmias After Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention. Liang JJ; Fender EA; Cha YM; Lennon RJ; Prasad A; Barsness GW Am J Cardiol; 2016 Mar; 117(5):709-13. PubMed ID: 26796195 [TBL] [Abstract][Full Text] [Related]
39. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent. Karha J; Bavry AA; Rajagopal V; Henderson MR; Ellis SG; Brener SJ Am J Cardiol; 2006 Sep; 98(5):616-8. PubMed ID: 16923447 [TBL] [Abstract][Full Text] [Related]
40. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]